secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001493152-25-020750
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics 2025 annual meeting elects directors, approves equity plan amendment, ratifies auditor
--------------------------------------------------------------------------------

- All six director nominees elected: Huntsman, Green, Krammer, Lindsay, Sokolow, Thompson; each with >2.6M votes for.
- Amendment to 2024 Omnibus Equity Incentive Plan approved with 2.45M for, 516K against, 2.3K abstain.
- Appointment of Baker Tilly US, LLP as auditor for FY ending Dec 31, 2025 ratified with 4.86M for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/0001493152-25-020750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315225020750/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-020750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer